Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX is ...

DeNovX Establishes Strategic R&D Collaboration with Scientists at Massachusetts Institute of Technology (MIT)

Posted 10/9/2019

In March of this year, DeNovX and MIT finalized details of a collaborative agreement to continue development of patented continuous flow crystallization methods. This effort is sponsored by the National Institutes of Health through a Phase II SBIR award to DeNovX, and the work seeks to improve manufacturing-scale crystallization of pharmaceuticals by leveraging the unparalleled efficiency and safety advantages of continuous flow manufacturing.